Krajsová, Ivana <br/><br/>
Long-term Survival with Ipilimumab: Experience from a National Expanded Access Program for Patients with Melanoma.  [electronic resource] 

 -  Anticancer research  Nov 2015 
 - 6303-10 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1791-7530 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>C-Reactive Protein--metabolism<br/>Drug Resistance, Neoplasm--drug effects<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Ipilimumab<br/>L-Lactate Dehydrogenase--metabolism<br/>Male<br/>Melanoma--drug therapy<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Neoplasm Recurrence, Local--drug therapy<br/>Neoplasm Staging<br/>Prognosis<br/>Safety<br/>Salvage Therapy<br/>Survival Rate<br/>Time Factors<br/>Young Adult